Asthma is a prevalent chronic disease and occupation contributes to approximately 15 % of cases among adults. However, there are still few studies on risk factors for work-exacerbated asthma. The current study investigated the association between asthma exacerbations and occupational exposures. The study comprised all currently working adults (n = 1356) who reported ever asthma in prior population-based cohorts. All subjects completed a questionnaire about exposures, occupations and exacerbations of asthma. Exposure to high and low molecular weight agents, irritating agents and asthmagens were classified using the asthma-specific job exposure matrix for northern Europe (N-JEM). Severe exacerbation of asthma was defined as sought emergency care at a hospital, admitted to a hospital overnight, or made an urgent visit to a primary care physician or district medical office due to breathing problems during the last 12 months. Moderate exacerbation was defined as both being not severe exacerbation and an additional visit to a primary care physician or district medical office, or had extra treatments with corticosteroid tablets. Mild exacerbation was defined as being neither severe nor moderate exacerbation, and increasing usage of inhaled corticosteroids. Multiple logistic regression was applied to investigate the association between exacerbation of asthma and occupational exposures while adjusting for potential confounders. Approximately 26 % of the working asthmatics reported exacerbation, and more than two-thirds of them had moderate or severe exacerbation. From 23 to 49 % of the asthmatics reported occupational exposure to a variety of different types of agents. Exposure to any gas, smoke or dust (OR 1.7[95 % CI 1.2–2.6]) was associated with severe exacerbation of asthma, as were organic dust (OR 1.7[1.2–2.5]), dampness and mold (OR 1.8[1.2–2.7]), cold conditions (OR 1.7[1.1–2.7]), and a physically strenuous job (OR 1.6[1.03–2.3]). Asthmagens and low molecular weight agents classified by the N-JEM were associated with mild exacerbation, with OR 1.6[1.1–2.5] and OR 2.2[1.1–4.4], respectively. Self-reported exposure to any gas, smoke or dust, organic dust, dampness and mold, cold conditions and physically strenuous work, and jobs handling low molecular weight agents were associated with exacerbation of asthma. Reduction of these occupational exposures may help to reduce exacerbation of asthma.
Background: Evidence of the role of interactions between air pollution and pollen exposure in subjects with allergic asthma is limited and need further exploration to promote adequate preventive measures. The objective of this study was to assess effects of exposure to ambient air pollution and birch pollen on exacerbation of respiratory symptoms in subjects with asthma and allergy to birch.Methods: Thirty-seven subjects from two Swedish cities (Gothenburg and Umeå) with large variation in exposure to both birch-pollen and air pollutants, participated in the study. All subjects had confirmed allergy to birch and self-reported physician-diagnosed asthma. The subjects recorded respiratory symptoms such as rhinitis or eye irritation, dry cough, dyspnoea, the use of any asthma or allergy medication and peak respiratory flow (PEF), daily for five consecutive weeks during two separate pollen seasons and a control season without pollen. Nitrogen oxides (NOx), ozone (O3), particulate matter (PM2.5), birch pollen counts, and meteorological data were obtained from an urban background monitoring stations in the study city centres. The data were analysed using linear mixed effects models.Results: During pollen seasons all symptoms and medication use were higher, and PEF was reduced in the subjects. In regression analysis, exposure to pollen at lags 0 to 2 days, and lags 0 to 6 days was associated with increased ORs of symptoms and decreased RRs for PEF. Pollen and air pollution interacted in some cases; during low pollen exposure, there were no associations between air pollution and symptoms, but during high pollen exposure, O3concentrations were associated with increased OR of rhinitis or eye irritation, and PM2.5concentrations were associated with increased ORs of rhinitis or eye irritation, dyspnea and increased use of allergy medication.Conclusions: Pollen and air pollutants interacted to increase the effect of air pollution on respiratory symptoms in allergic asthma. Implementing the results from this study, advisories for individuals with allergic asthma could be improved, minimizing the morbidities associated with the condition.
Introduction: Air pollution and allergen exposure can cause severe respiratory effects, especially in subjects with asthma. The impact on the small airway lining fluid remains uncertain. Aim: To explore the influence of air pollution and pollen exposure on the phospholipid composition of the small airway lining fluid and if subjects with allergic asthma respond differently than healthy. Methods: In subjects with asthma (n=23) and healthy (n=13), exposure to ozone (O3), nitrogen oxides (NOx), and particulate matter (PM10) was measured prior to clinical examination in two pollen seasons and outside the pollen season. Associations between exposure and lipids were analyzed using mixed effects regression. Results: In total, 78 lipids were quantified. Five lipids showed significant lower responses in the asthma group than in healthy. Interactions between season and exposure were identified for 7 lipids, but differences were not consistent. In healthy, 41 lipids were significantly associated with any of the exposures, whereas only 6 lipids in asthma. Conclusions: Our results identified significant differences in response to exposure between subjects with asthma and healthy. As the lining fluid represent the first barrier of defense to inhaled material, our findings are of clinical significance. Differences in response between subjects with asthma and healthy erj;64/suppl_68/PA4890/T1 T1 t1 Lipid Exposure (µg/m3) Estimates# p q† PE(O-2:0/20:4) NOx −2.0E-04 0.0004 0.08 PC(16:0_18:3) NOx −1.8E-03 0.0009 0.08 PC(14:1_16:0) PM10 7.6E-02 0.002 0.11 PC(18:0_18:1) O3 1.3E-02 0.008 0.30 PI(18:0_18:1) O3 1.9E-02 0.008 0.30 #Lipid mol% differences between the groups per unit change in exposure in µg/m3 †Adjusted false discovery rates (q)